Current Edition

Roundtable: The Continuing Evolution of Bioinformatics in the Pharma Industry

In life sciences, research, advances in instrumentation, new types of measurements that are now possible and improved computational tools are generating not only significantly more data than ever before but also more diverse modalities and higher resolution data. Marilyn Matz and Zachary Pitluk at Paradigm4 discuss how pharma and biopharma organisations, can leverage the new ‘mountain’ of available data to open the potential for them to expedite the discovery and delivery of new, more effective, safer therapies for patients.